Viewing nowAnaprazole 20 mg Tablets (Esomeprazole Magnesium Trihydrate)
Esomeprazole Magnesium Trihydrate 21.69mg
Tablet · Prescription medication
Ajou Pharmaceutical Co., Ltd.

MFDS item code 201507644 · Approved 2015.11.10 · Insurance code 654004700
Treatment and prevention of gastroesophageal reflux and gastrointestinal symptoms, ulcers (including eradication therapy), and Zollinger-Ellison syndrome
This medication is used to treat gastroesophageal reflux disease and erosive reflux esophagitis, as well as for long-term maintenance therapy to prevent recurrence of esophagitis. It is used as part of a combination therapy with effective antibiotics for the treatment of duodenal ulcers and peptic ulcers in patients with Helicobacter pylori infection and to prevent recurrence. Additionally, it is used to treat upper gastrointestinal symptoms related to the use of non-steroidal anti-inflammatory drugs and in the treatment of gastric ulcers, as well as for prevention of gastric and duodenal ulcers. It also applies to the treatment of Zollinger-Ellison syndrome and for the prevention and maintenance therapy of rebleeding due to gastric ulcers or duodenal ulcers. Overall, it is widely used in the treatment and prevention of gastrointestinal-related diseases to improve symptoms and help maintain health.
This medicine must be swallowed with a liquid such as water and must not be chewed or crushed. 1. Adults 1) Gastroesophageal reflux disease (GERD). - Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. For patients whose esophagitis is not healed or whose symptoms persist, continue treatment for an additional 4 weeks. - Long-term maintenance therapy to prevent recurrence in patients with esophagitis: 20 mg once daily - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: · 20 mg once daily. If symptoms are not controlled after 4 weeks, further medical evaluation is required. · Once symptoms have improved, subsequent recurring symptoms may be controlled by administering 20 mg once daily. · In adults, 20 mg may be administered once daily as needed. For patients at high risk of developing gastric and duodenal ulcers due to treatment with nonsteroidal anti-inflammatory drugs, administration as needed is not recommended for controlling recurring symptoms. 2) Combination therapy with antibiotics for Helicobacter pylori eradication Administer this medicine 20 mg with amoxicillin 1 g and clarithromycin 500 mg twice daily for 7 days. 3) Short-term treatment of upper gastrointestinal symptoms (pain, discomfort, burning sensation) associated with use of nonsteroidal anti-inflammatory drugs (nonselective or selective COX-2 inhibitors) - 20 mg once daily. If symptoms are not controlled after 4 weeks, further medical evaluation is required. No clinical studies have been conducted for periods exceeding 4 weeks. 4) Patients requiring continuous treatment with nonsteroidal anti-inflammatory drugs - Treatment of gastric ulcers associated with use of nonsteroidal anti-inflammatory drugs: 20 mg once daily. The treatment period is 4∼8 weeks. - Prevention of gastric and duodenal ulcers associated with use of nonsteroidal anti-inflammatory drugs: 20 mg once daily. 5) Treatment of Zollinger-Ellison syndrome The recommended initial dose is 40 mg twice daily. Thereafter, the dose should be adjusted for each patient, and treatment should be continued while clinical symptoms are present. Clinical data indicate that most patients can be controlled with doses of 80 ∼ 160 mg daily. Doses above 80 mg daily should be divided into 2 doses. 6) Maintenance therapy following induction of prevention of rebleeding due to gastric or duodenal ulcers with intravenous treatment Administer 40 mg once daily for 4 weeks following induction of prevention of rebleeding due to gastric or duodenal ulcers with intravenous treatment. 4. Renal impairment No dose adjustment is necessary. Since there is limited experience with administration to patients with severe renal failure, administer with caution. 5. Hepatic impairment No dose adjustment is necessary in patients with mild to moderate hepatic impairment. In patients with severe hepatic impairment, the dose of this medicine must not exceed 20 mg. 6. Elderly patients No dose adjustment is necessary.
2. Adolescents aged 12 years and older 1) Gastroesophageal reflux disease (GERD) - Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. For patients whose esophagitis has not healed or whose symptoms persist, continue treatment for an additional 4 weeks. - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: · 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is required. · Once symptoms have resolved, subsequent recurrent symptoms may be controlled by administering 20 mg once daily. 3. Children under 12 years of age There is no experience with administration of this drug to children under 12 years of age.
This medication should not be used in individuals with allergies or a history of hypersensitivity to certain ingredients or benzimidazole derivatives. Patients taking some antibiotics or antivirals used in the eradication of Helicobacter pylori should also avoid this medication, as well as those with a history of myocardial infarction or those who are breastfeeding. This medication contains a dye called Yellow No. 5, so people with allergy reactions to this ingredient should use it with caution. Rarely, the use of this medication may result in various side effects such as blood abnormalities, allergic reactions, electrolyte imbalances, neurological symptoms, gastrointestinal disturbances, liver dysfunction, skin rashes, and more. If any symptoms arise, immediate consultation with a physician is required. Long-term use of this medication may lead to electrolyte imbalances such as hypomagnesemia, necessitating regular testing. Moreover, since this medication suppresses gastric acid secretion, there is a slightly increased risk of bacterial infections in the gastrointestinal tract, so if abnormal symptoms such as diarrhea persist, the healthcare provider should be informed. Patients at risk of osteoporosis or fractures should be cautious, as the long-term use of this medication may increase the risk of fractures. This medication can interact with various drugs, so if other medications are being taken, individuals must inform their healthcare provider, particularly when used alongside anticoagulants, antibiotics, antivirals, and anticonvulsants. Women who are pregnant or breastfeeding must consult with a physician before using this medication, and it is safest for breastfeeding mothers not to use this medication. In the case of overdose, there is no specific antidote available, so appropriate treatment should be provided according to symptoms, and it should be kept out of reach of children.
Leukopenia, thrombocytopenia, agranulocytosis, pancytopenia, fever, angioedema, anaphylactic reaction, shock, peripheral edema, hyponatremia, hypomagnesemia, insomnia, agitation, confusion, depression, aggression, hallucinations, headache, dizziness, paresthesia, drowsiness, taste disorder, blurred vision, bronchospasm, pancreatitis, abdominal pain, constipation, diarrhea, abdominal bloating, nausea, vomiting, dry mouth, stomatitis, gastrointestinal candidiasis, microscopic colitis, elevated liver enzymes, hepatitis, jaundice, liver failure, encephalopathy, dermatitis, itching, rash, urticaria, hair loss, photosensitivity, erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis, acute generalized exanthematous pustulosis, drug reaction with eosinophilia and systemic symptoms, fracture, arthralgia, myalgia, muscle weakness, interstitial nephritis, gynecomastia, asthenia, increased sweating, Clostridium difficile-associated diarrhea, abdominal distension, allergic reaction, back pain, chest pain, sternal chest pain, facial edema, facial flushing, fatigue, influenza-like illness, generalized edema, leg edema, malaise, pain, stiffness, anemia, hypopigmented anemia, cervical lymphadenopathy, epistaxis, leukocytosis, leukopenia, thrombocytopenia, hyperbilirubinemia, liver dysfunction, increased ALT, increased AST, diabetes, hyperuricemia, increased ALP, dry mouth, vitamin B12 deficiency, weight gain, weight loss, exacerbation of arthritis, arthropathy, seizures, fibromyalgia syndrome, hernia, polymyalgia rheumatica, loss of appetite, apathy, increased appetite, confusion, worsening depression, hypertonia, sensory loss, erectile dysfunction, insomnia, migraine, exacerbation of migraine, sleep disorders, tremors, visual field loss, dysmenorrhea, menstrual disorders, vaginitis, exacerbation of asthma, cough, dyspnea, laryngeal edema, pharyngitis, rhinitis, sinusitis, acne, anal itching, erythematous rash, papular rash, otitis media, dysosmia, loss of taste, taste distortion, abnormal urination, albuminuria, cystitis, dysuria, fungal infection, hematuria, frequency of urination, candidiasis, genital candidiasis, polyuria, conjunctivitis, visual disturbances, duodenitis, esophagitis, esophageal stricture, esophageal ulcer, esophageal varices, gastric ulcer, gastritis, benign polyp or nodule, Barrett's esophagus, mucosal discoloration, hernia, systemic lupus erythematosus, cutaneous lupus erythematosus, gastric fundic polyps, hypocalcemia, hypokalemia, rhabdomyolysis, myalgia, increased creatine kinase, elevated myoglobin in blood and urine, Stevens-Johnson syndrome, toxic epidermal necrolysis, drug reaction with eosinophilia and systemic symptoms, acute generalized exanthematous pustulosis
Not everyone experiences these, and they can vary from person to person.
This medication can be sensitive to air or moisture, so it should be stored in a tightly closed container. Additionally, it is important to store it at room temperature between 1°C and 30°C to maintain its effectiveness.
Pale pink round film-coated tablet
Box - 28 tablets/box [14 tablets/PTP x 2]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowEsomeprazole Magnesium Trihydrate 21.69mg
Tablet · Prescription medication
Ajou Pharmaceutical Co., Ltd.

Esomeprazole Magnesium Trihydrate 44.5mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Esomeprazole Magnesium Trihydrate 44.5mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Esomeprazole Magnesium Dihydrate 43.38mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Esomeprazole Magnesium Dihydrate 21.69mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
Samjin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.